New research: Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer: Background: Osimertinib is a 3rd-generation tyrosine kinase inhibitor (TKI) that blocks the epidermal… https://t.co/
6,544 followers
966 followers
RT @patilmd3: Thank you for the shoutout! A potentially important (albeit rare) side effect of osimertinib, especially as higher doses are…
952 followers
RT @patilmd3: Thank you for the shoutout! A potentially important (albeit rare) side effect of osimertinib, especially as higher doses are…
3,747 followers
RT @StephenVLiu: #OncoAlert Interesting case series highlighting several cases of cecal volvulus in patients receiving osimertinib 160mg fo…